Name

CellTech

Legal name

快看影院

Website

https://hlcelltech.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Video Streaming

NAICS

Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (5162)

SIC

Services-Amusement & Recreation Services (7900)

akta.pro primary industry

International/Multilingual Streaming Channels (MPABAHAI)

akta.pro secondary industries

Anime & Niche Genre Streaming Platforms (Horror/Faith/Indie/etc.) (MPACAAAH), Digital Content & Media Subscriptions (CRAFAIAA)

Keywords

• Video streaming
• Online entertainment
• Movie streaming
• TV series streaming
• Anime streaming

Headquarters

HQ city

Shuanggang

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Operations, Supply Chain, Infrastructure, Technology or R&D

Core offering

Operates an online video streaming platform under the KuaiKan Cinema (快看影院) brand, aggregating movies, TV series, variety shows, anime, short dramas, and curated Netflix content for Chinese-speaking audiences. The site offers VIP-branded access and organizes content by genre and regional origin, serving viewers in China, Taiwan, Japan, and Thailand.

Differentiator

Problem solved

Functional benefit

Products and services

• KuaiKan Cinema Streaming Platform (快看影院) Web-based video streaming platform offering on-demand access to a broad catalog of Chinese-language entertainment content organized by genre (action, comedy, romance, sci-fi, horror, drama), regional origin (mainland China, Hong Kong, Taiwan, Japan, Korea, Thailand, US), and format (movies, TV series, variety shows, anime, short dramas, Netflix titles). Includes VIP-branded access tiers.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered flagship and core.

• RegeneronflagshipStrategic or Co-development PartnerPartnership with Regeneron to co-develop cell therapies for Crohn's disease, ulcerative colitis, and other autoimmune conditions. This is a significant co-development collaboration leveraging CellTech's regulatory T cell research platform.
• Sonoma BiotherapeuticscoreStrategic or Co-development PartnerSonoma Biotherapeutics is a Seattle- and South San Francisco-based company co-founded by Fred Ramsdell, applying the regulatory T cell research from Darwin Molecular to commercial cell therapy development.
• Osaka UniversitycoreStrategic or Co-development PartnerResearch collaboration with Shimon Sakaguchi of Osaka University in Japan; Sakaguchi shared the 2024 Nobel Prize with Fred Ramsdell and Mary Brunkow for work on regulatory T cells.

Scale indicators2 records

Recent moves2 records

Emerging players

• DramaBox: Short-form vertical-drama streaming platform operated by Storymatrix / Tencent-backed entity. Comparable as a direct competitor in the short-form drama vertical that is a flagship category for CellTech.
• ReelShort: Crazy Maple Studio's short-form vertical-drama app that has rapidly scaled globally on the back of the mini-drama format boom. Comparable because CellTech's 短剧 section sits in the same short-form drama category ReelShort pioneered.

Broad incumbents

• Bilibili: Major Chinese video and anime streaming platform with user-generated and licensed content. Comparable because it is an Asian entertainment destination with anime as a flagship vertical and a freemium/VIP model — the same audience and monetization pattern CellTech targets.
• Mango TV: Hunan Broadcasting System's streaming platform offering dramas, variety shows and original series. Comparable as another major Chinese free/paid streaming competitor in CellTech's target content categories.
• Youku: Alibaba-owned streaming platform with broad catalog of films, series, anime and variety content. Comparable as one of the dominant free + VIP streaming destinations competing for the same viewers as CellTech.
• WeTV: Tencent's international streaming brand distributing Chinese and Asian dramas across Southeast Asia and beyond. Comparable as a regional multi-language Asian streaming competitor targeting overlapping territories (Thailand, Japan, Taiwan).
• iQiyi: One of China's "Big Three" streaming services, with a broad library of movies, TV series, anime, and originals, plus a paid VIP tier. Comparable as a direct competitor to CellTech in the mainland Chinese free + VIP streaming category.
• Kuaishou: Leading Chinese short-video and short-form drama platform with a massive user base and built-in monetization. Comparable as both a content competitor in 短剧 and an indirect competitor for short-form video viewing time.
• Tencent Video: Tencent's flagship streaming service offering movies, TV dramas, anime, variety shows and originals across Greater China. Comparable as a direct competitor in CellTech's primary mainland-China content verticals.

Regional players

• Viu: PCCW-operated Asian OTT streaming service focused on Korean, Japanese, and other pan-Asian drama content in Southeast Asia. Comparable because it shares CellTech's emphasis on serving Chinese/Taiwan/Japanese/Thai audiences with multi-market Asian content.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CellTech